Rheddos System™: Drug Discovery Optimization Service
Principle: integrate biosimulation The service that Rhenovia proposes to pharma and biotech companies is an interactive partnership to evaluate their drug discovery process by analyzing drug's effects on integrated biological systems and by searching synergistic drug / mechanism combinations. Thus, Rhenovia proposes to...
Example of a contract signed with a pharma partner
Based on Rhenovia's claims that
A - Combining a drug candidate with another appropriate compound may result in synergistic increase of efficacy
B- Showing improved efficacy of such a drug candidate can provide competitive advantage
the client which has in PhII clinical development 25 drug candidates with various modes
of action asks to identify paired combinations of these compounds that result in
synergistic pharmacological effects.
Memory platform for cognitive deficits and glutamate/GABA imbalance
The first operational service offered to pharma and biotech partners is directed towards drug candidates and mechanisms involved in learning and memory...
Rhenovia's goal is to tailor its service and adapt its technology platforms to specific needs of pharma and biotech partners. Starting from generic platforms, Rhenovia can modify the level complexity at synaptic, to neuronal or network levels. Platforms can also be extended to other NS functions and pathologies, neuronal circuits, or functional read-outs....